1
|
Escajadillo T, Olson J, Luk BT, Zhang L, Nizet V. A Red Blood Cell Membrane-Camouflaged Nanoparticle Counteracts Streptolysin O-Mediated Virulence Phenotypes of Invasive Group A Streptococcus. Front Pharmacol 2017; 8:477. [PMID: 28769806 PMCID: PMC5513932 DOI: 10.3389/fphar.2017.00477] [Citation(s) in RCA: 44] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2017] [Accepted: 07/03/2017] [Indexed: 12/16/2022] Open
Abstract
Group A Streptococcus (GAS), an important human-specific Gram-positive bacterial pathogen, is associated with a broad spectrum of disease, ranging from mild superficial infections such as pharyngitis and impetigo, to serious invasive infections including necrotizing fasciitis and streptococcal toxic shock syndrome. The GAS pore-forming streptolysin O (SLO) is a well characterized virulence factor produced by nearly all GAS clinical isolates. High level expression of SLO is epidemiologically linked to intercontinental dissemination of hypervirulent clonotypes and poor clinical outcomes. SLO can trigger macrophage and neutrophil cell death and/or the inactivation of immune cell functions, and promotes tissue injury and bacterial survival in animal models of infection. In the present work, we describe how the pharmacological presentation of red blood cell (RBC) derived biomimetic nanoparticles ("nanosponges") can sequester SLO and block the ability of GAS to damage host cells, thereby preserving innate immune function and increasing bacterial clearance in vitro and in vivo. Nanosponge administration protected human neutrophils, macrophages, and keratinocytes against SLO-mediated cytotoxicity. This therapeutic intervention prevented SLO-induced macrophage apoptosis and increased neutrophil extracellular trap formation, allowing increased GAS killing by the respective phagocytic cell types. In a murine model of GAS necrotizing skin infection, local administration of the biomimetic nanosponges was associated with decreased lesion size and reduced bacterial colony-forming unit recovery. Utilization of a toxin decoy and capture platform that inactivates the secreted SLO before it contacts the host cell membrane, presents a novel virulence factor targeted strategy that could be a powerful adjunctive therapy in severe GAS infections where morbidity and mortality are high despite antibiotic treatment.
Collapse
Affiliation(s)
- Tamara Escajadillo
- Biomedical Sciences Graduate Program, University of California, San Diego, La JollaCA, United States.,Department of Pediatrics, Division of Host-Microbe Systems and Therapeutics, University of California, San Diego, La JollaCA, United States
| | - Joshua Olson
- Department of Pediatrics, Division of Host-Microbe Systems and Therapeutics, University of California, San Diego, La JollaCA, United States
| | - Brian T Luk
- Department of NanoEngineering, University of California, San Diego, La JollaCA, United States
| | - Liangfang Zhang
- Department of NanoEngineering, University of California, San Diego, La JollaCA, United States
| | - Victor Nizet
- Biomedical Sciences Graduate Program, University of California, San Diego, La JollaCA, United States.,Department of Pediatrics, Division of Host-Microbe Systems and Therapeutics, University of California, San Diego, La JollaCA, United States.,Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La JollaCA, United States
| |
Collapse
|